Home Acerta Pharma

Acerta Pharma

acquired
Series A
Acerta Pharma is committed to developing covalent binding technology solutions to create cancer treatments.

Basic Information

Acerta Pharma is dedicated to developing covalent binding technology solutions to create cancer treatments, and the company develops drugs for oncology and autoimmune disease research.
Acerta Pharma
United States of America
51~100 people
January 01, 2013
info@acerta-pharma.com